Last 1,482 GBp
Change Today -73.50 / -4.73%
Volume 22.9M
GSK On Other Exchanges
Symbol
Exchange
OTC US
New York
Xetra
Frankfurt
As of 11:35 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ellen Strahlman M.D., M.H.Sc.

Chief Medical Officer and Senior Vice President of Research & Development, Becton, Dickinson and Company
AgeTotal Calculated CompensationThis person is connected to 16 board members in 2 different organizations across 4 different industries.

See Board Relationships
57--

Background*

Dr. Ellen Strahlman, M.D. M.H.Sc., has been the Chief Medical Officer and Senior Vice President of Research & Development of Becton, Dickinson and Company since April 22, 2013. Dr. Strahlman served as the Chief Medical Officer of GlaxoSmithKline plc since September 9, 2008. Dr. Strahlman joined GSK from Pfizer Inc., where she served Vice President of Licensing, Worldwide Business Development. She served as Chief Executive Officer of Virogen Limited, a biotechnology company; ...

Read Full Background

Corporate Headquarters*

980 Great West Road
Brentford, Middlesex TW8 9GS

United Kingdom

Phone: 44 20 8047 5000
Fax: --

Board Members Memberships*

Non Executive Director
Director

Education*

BA
Harvard University
Unknown/Other Education
Johns Hopkins School of Medicine
MD
Johns Hopkins School of Medicine
Master's Degree
Johns Hopkins Bloomberg School of Public Health

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:LN 1,481.50 GBp -73.50

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kevin A. Lobo Chairman, Chief Executive Officer and President
Stryker Corporation
$1.0M
William P. Sullivan Chief Executive Officer, President, Executive Director and Member of Executive Committee
Agilent Technologies Inc.
$1.0M
David C. Dvorak Chief Executive Officer, President and Director
Zimmer Holdings, Inc.
$904.0K
Michael F. Mahoney Chief Executive Officer, President and Director
Boston Scientific Corporation
$900.0K
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.